Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience
- PMID: 32195705
- PMCID: PMC7155908
- DOI: 10.1097/ALN.0000000000003296
Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience
Abstract
The COVID-19 outbreak has led to 80,409 diagnosed cases and 3,012 deaths in mainland China based on the data released on March 4, 2020. Approximately 3.2% of patients with COVID-19 required intubation and invasive ventilation at some point in the disease course. Providing best practices regarding intubation and ventilation for an overwhelming number of patients with COVID-19 amid an enhanced risk of cross-infection is a daunting undertaking. The authors presented the experience of caring for the critically ill patients with COVID-19 in Wuhan. It is extremely important to follow strict self-protection precautions. Timely, but not premature, intubation is crucial to counter a progressively enlarging oxygen debt despite high-flow oxygen therapy and bilevel positive airway pressure ventilation. Thorough preparation, satisfactory preoxygenation, modified rapid sequence induction, and rapid intubation using a video laryngoscope are widely used intubation strategies in Wuhan. Lung-protective ventilation, prone position ventilation, and adequate sedation and analgesia are essential components of ventilation management.
Figures









Comment in
-
Intubation and Ventilation amid COVID-19: Comment.Anesthesiology. 2020 Aug;133(2):464-465. doi: 10.1097/ALN.0000000000003374. Anesthesiology. 2020. PMID: 32371757 Free PMC article. No abstract available.
-
Deaths in healthcare workers due to COVID-19: the need for robust data and analysis.Anaesthesia. 2020 Aug;75(8):989-992. doi: 10.1111/anae.15116. Epub 2020 May 23. Anaesthesia. 2020. PMID: 32397005 Free PMC article. No abstract available.
References
-
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. [Epub ahead of print]. DOI: 10.1056/NEJMoa2002032 - PMC - PubMed
-
- Gates B. Responding to COVID-19—A once-in-a-century pandemic? N Engl J Med 2020. [Epub ahead of print]. DOI: 10.1056/NEJMp2003762 - PubMed
-
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 2020. [Epub ahead of print]. DOI: 10.1016/S2213-2600(20)30079-5 - PMC - PubMed
-
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020. [Epub ahead of print]. DOI:10.1001/jama.2020.1585 - PMC - PubMed
-
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506 - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical